Youth depression alleviation with anti-inflammatory agents (YoDA-A): A placebo-controlled randomised augmentation trial of rosuvastatin and aspirin
Version 2 2024-06-05, 10:40Version 2 2024-06-05, 10:40
Version 1 2019-04-01, 10:15Version 1 2019-04-01, 10:15
conference contribution
posted on 2024-06-05, 10:40 authored by Michael BerkMichael Berk, M Mohammadreza, Olivia DeanOlivia Dean, SM Cotton, AM Chanen, Seetal DoddSeetal Dodd, A Ratheesh, GP Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, Melissa O'SheaMelissa O'Shea, MR Schafer, E Mullen, S Hetrick, M Kerr, SM Harrigan, AL Quinn, PD McGorry, CG DaveyYouth depression alleviation with anti-inflammatory agents (YoDA-A): A placebo-controlled randomised augmentation trial of rosuvastatin and aspirin
History
Volume
21Pagination
14-14Location
Sydney, AUSTRALIAStart date
2019-03-20End date
2019-03-23ISSN
1398-5647eISSN
1399-5618Language
EnglishPublication classification
E3 Extract of paperTitle of proceedings
BIPOLAR DISORDERSEvent
21st Annual ISBD Conference on Global Advances in Bipolar Disorder and DepressionPublisher
WILEYUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPsychiatryNeurosciences & Neurology3202 Clinical sciences3209 NeurosciencesSchool of MedicineInstitute for Innovation in Mental and Physical Health and Clinical TranslationFaculty of Health420313 Mental health services200409 Mental health
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC